Display options
Cite
Afzal MS. Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective. World J Hepatol. 2016;8(26):1116-8doi: 10.4254/wjh.v8.i26.1116.
Afzal, M. S. (2016). Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective. World journal of hepatology, 8(26), 1116-8. https://doi.org/10.4254/wjh.v8.i26.1116
Afzal, Muhammad Sohail. "Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective." World journal of hepatology vol. 8,26 (2016): 1116-8. doi: https://doi.org/10.4254/wjh.v8.i26.1116
Afzal MS. Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective. World J Hepatol. 2016 Sep 18;8(26):1116-8. doi: 10.4254/wjh.v8.i26.1116. PMID: 27660680; PMCID: PMC5026995.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2016 Sep 18;8(26):1116-8. doi: 10.4254/wjh.v8.i26.1116.

Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective.

World journal of hepatology

Muhammad Sohail Afzal

Affiliations

  1. Muhammad Sohail Afzal, Department of Chemistry, School of Science, University of Management and Technology, Lahore 54000, Pakistan.

PMID: 27660680 PMCID: PMC5026995 DOI: 10.4254/wjh.v8.i26.1116

Abstract

In Pakistan which ranked second in terms of hepatitis C virus (HCV) infection, it is highly needed to have an established diagnostic test for antiviral therapy response prediction. Interleukin 28B (IL-28B) genetic testing is widely used throughout the world for interferon based therapy prediction for HCV patients and is quite helpful not only for health care workers but also for the patients. There is a strong relationship between single nucleotide polymorphisms at or near the IL-28B gene and the sustained virological response with pegylated interferon plus ribavirin treatment for chronic hepatitis C. Pakistan is a resource limited country, with very low per capita income and there is no proper social security (health insurance) system. The allocated health budget by the government is very low and is used on other health emergencies like polio virus and dengue virus infection. Therefore it is proposed that there should be a well established diagnostic test on the basis of IL-28B which can predict the antiviral therapy response to strengthen health care set-up of Pakistan. This test once established will help in better management of HCV infected patients.

Keywords: Diagnostics; Genetic testing; Hepatitis C virus; IL-28B; Interferon therapy; Pakistan; Polymorphisms

References

  1. Genes Immun. 2014 Sep;15(6):430-2 - PubMed
  2. Nat Genet. 2009 Oct;41(10):1100-4 - PubMed
  3. Int J Infect Dis. 2015 Jan;30:91-7 - PubMed
  4. Asian Pac J Cancer Prev. 2015;16(13):5583-4 - PubMed
  5. Hepat Mon. 2014 Jan 12;14(1):e11466 - PubMed
  6. Mol Med Rep. 2013 Aug;8(2):487-92 - PubMed
  7. Nat Genet. 2009 Oct;41(10):1105-9 - PubMed
  8. Hepat Mon. 2014 Jan 06;14(1):e11879 - PubMed
  9. Virol J. 2013 Oct 01;10:299 - PubMed
  10. Braz J Infect Dis. 2016 May-Jun;20(3):312-3 - PubMed
  11. Asian Pac J Cancer Prev. 2015 ;16(3):1037-40 - PubMed
  12. APMIS. 2015 Sep;123(9):765-71 - PubMed
  13. World J Gastroenterol. 2014 Dec 14;20(46):17690-2 - PubMed
  14. J Dig Dis. 2015 May;16(5):293-8 - PubMed
  15. APMIS. 2015 Apr;123(4):342-9 - PubMed
  16. J Med Virol. 2015 May;87(5):814-20 - PubMed
  17. Nature. 2009 Sep 17;461(7262):399-401 - PubMed
  18. Asian Pac J Trop Med. 2016 Jun;9(6):616-8 - PubMed
  19. Virol J. 2012 Jan 14;9:18 - PubMed

Publication Types